COVID-19 and antimicrobial stewardship: What is the interplay?

Nikolaos A Spernovasilis¹, Diamantis P Kofteridis^{1

2}

Affiliations

¹ Internal Medicine Department, Infectious Diseases Unit, University Hospital of Heraklion, Heraklion, Greece.
² Faculty of Medicine, University of Crete, Heraklion, Greece.

Nikolaos A Spernovasilis et al. Infect Control Hosp Epidemiol. 2021 Mar.

. 2021 Mar;42(3):378-379.

doi: 10.1017/ice.2020.246. Epub 2020 May 15.

Nikolaos A Spernovasilis¹, Diamantis P Kofteridis^{1

2}

¹ Internal Medicine Department, Infectious Diseases Unit, University Hospital of Heraklion, Heraklion, Greece.
² Faculty of Medicine, University of Crete, Heraklion, Greece.

No abstract available

References

1. Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis 2020. doi: 10.1093/cid/ciaa530. - DOI - PMC - PubMed
1. Gautret P, Lagier JC, Parola P, et al. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow-up: a pilot observational study. Travel Med Infect Dis 2020. doi: 10.1016/j.tmaid.2020.101663. - DOI - PMC - PubMed
1. Molina JM, Delaugerre C, Le Goff J, et al. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. Médecine et Maladies Infectieuses 2020. doi: 10.1016/j.medmal.2020.03.006. - DOI - PMC - PubMed
1. Cox MJ, Loman N, Bogaert D, O’Grady J. Coinfections: potentially lethal and unexplored in COVID-19. Lancet Microbe 2020. doi: 10.1016/S2666-5247(20)30009-4. - DOI - PMC - PubMed
1. Arabi YM, Deeb AM, Al-Hameed F, et al. Macrolides in critically ill patients with Middle East respiratory syndrome. Int J Infect Dis 2019;81:184–190. - PMC - PubMed